JP2024530956A5 - - Google Patents

Info

Publication number
JP2024530956A5
JP2024530956A5 JP2024508668A JP2024508668A JP2024530956A5 JP 2024530956 A5 JP2024530956 A5 JP 2024530956A5 JP 2024508668 A JP2024508668 A JP 2024508668A JP 2024508668 A JP2024508668 A JP 2024508668A JP 2024530956 A5 JP2024530956 A5 JP 2024530956A5
Authority
JP
Japan
Prior art keywords
group
groups
alkyl
cancer
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024508668A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024530956A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2022/112259 external-priority patent/WO2023016562A1/zh
Publication of JP2024530956A publication Critical patent/JP2024530956A/ja
Publication of JP2024530956A5 publication Critical patent/JP2024530956A5/ja
Pending legal-status Critical Current

Links

JP2024508668A 2021-08-12 2022-08-12 多環式系化合物およびその使用 Pending JP2024530956A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
CN202110926274.3 2021-08-12
CN202110926274 2021-08-12
CN202111485631 2021-12-07
CN202111485631.3 2021-12-07
CN202210624529 2022-06-02
CN202210624529.5 2022-06-02
PCT/CN2022/112259 WO2023016562A1 (zh) 2021-08-12 2022-08-12 多环类化合物及其用途

Publications (2)

Publication Number Publication Date
JP2024530956A JP2024530956A (ja) 2024-08-27
JP2024530956A5 true JP2024530956A5 (https=) 2025-05-19

Family

ID=85199846

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024508668A Pending JP2024530956A (ja) 2021-08-12 2022-08-12 多環式系化合物およびその使用

Country Status (9)

Country Link
US (1) US20250154105A1 (https=)
EP (1) EP4385978A4 (https=)
JP (1) JP2024530956A (https=)
KR (1) KR20240046891A (https=)
CN (1) CN117677608A (https=)
AU (1) AU2022326724B2 (https=)
CA (1) CA3228542A1 (https=)
TW (1) TW202315613A (https=)
WO (1) WO2023016562A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7739051B2 (ja) 2020-06-10 2025-09-16 アムジエン・インコーポレーテツド シクロブチルジヒドロキノリンスルホンアミド化合物
JP2025503186A (ja) * 2022-01-26 2025-01-30 勤浩医▲葯▼（▲蘇▼州）有限公司 Ｍｔａｐ欠失型がん治療用メチオニンアデノシルトランスフェラーゼ２ａ阻害剤
IL320456A (en) * 2022-10-27 2025-06-01 Suzhou Genhouse Bio Co Ltd Phosphorus-containing compound, pharmaceutical composition and use thereof
WO2025037871A1 (ko) * 2023-08-11 2025-02-20 에스케이바이오팜 주식회사 트리사이클릭 화합물 및 이의 mat2a 저해제 용도
CN117327007B (zh) * 2023-09-26 2024-09-13 上海陶术生物科技有限公司 一种vt107的制备方法
WO2025108384A1 (zh) * 2023-11-21 2025-05-30 上海同源康医药有限公司 苯并五元杂环类衍生物及其应用
CN119528810B (zh) * 2024-12-09 2025-04-29 山东第一医科大学(山东省医学科学院) 喹啉类化合物及其应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5433594A (en) * 1992-11-19 1994-06-08 Dainippon Pharmaceutical Co. Ltd. 3,4-dihydro-1-(2-hydroxyphenyl)-2(1h)-quinoxalinone derivative and related compound
JPH07145152A (ja) * 1992-11-19 1995-06-06 Dainippon Pharmaceut Co Ltd ３，４−ジヒドロ−１−（２−ヒドロキシフェニル）−２（１ｈ）−キノキサリノン誘導体及び関連化合物
CN1325481C (zh) * 2002-12-31 2007-07-11 中国人民解放军63971部队 含喹喔啉酮结构的方酸菁染料
US9776995B2 (en) * 2013-06-12 2017-10-03 Amgen Inc. Bicyclic sulfonamide compounds as sodium channel inhibitors
WO2016022915A1 (en) * 2014-08-08 2016-02-11 The Regent Of The University Of California 6-sulfonylamino quinoline compounds as plant growth regulators
MX378012B (es) * 2015-12-18 2025-03-10 Amgen Inc Compuestos de alquinil dihidroquinolina sulfonamida.
JP6903663B2 (ja) * 2015-12-18 2021-07-14 アムジエン・インコーポレーテツド アルキルジヒドロキノリンスルホンアミド化合物
CN108658937A (zh) * 2017-03-28 2018-10-16 中国海洋大学 一种双环生物碱类化合物及其制备方法和应用
EP3643711A1 (en) * 2018-10-24 2020-04-29 Bayer Animal Health GmbH New anthelmintic compounds
KR20210108367A (ko) * 2018-11-09 2021-09-02 비바체 테라퓨틱스, 인크. 비시클릭 화합물
CA3142351A1 (en) * 2019-05-31 2020-12-03 Ikena Oncology, Inc. Tead inhibitors and uses thereof
CA3183948A1 (en) * 2020-06-10 2021-12-16 Amgen Inc. Heteroalkyl dihydroquinoline sulfonamide compounds
JP2021195367A (ja) * 2020-06-10 2021-12-27 アムジエン・インコーポレーテツド シクロプロピルジヒドロキノリンスルホンアミド化合物
JP7739051B2 (ja) * 2020-06-10 2025-09-16 アムジエン・インコーポレーテツド シクロブチルジヒドロキノリンスルホンアミド化合物
CN113372184B (zh) * 2021-03-26 2023-08-18 武汉大学 一种基于手性转移策略合成c–n轴手性菲啶酮类化合物的方法

Similar Documents

Publication Publication Date Title
JP2024530956A5 (https=)
RU2448096C2 (ru) Диарилгидантоины
JP2020517616A5 (https=)
RU2011152891A (ru) Диарилгидантоины
ES2911040T3 (es) Nuevos derivados de heteroaril amida como inhibidores selectivos de histona deacetilasa 1 y 2 (HDAC1/2)
JP2009515988A5 (https=)
JP2007511504A5 (https=)
JP2008528468A5 (https=)
JP2009541223A5 (https=)
RU2005140570A (ru) Фармацевтическая композиция, содержащая ингибитор гистондеацетилазы
JP2009515980A5 (https=)
JP2011509949A5 (https=)
RU2008126245A (ru) Комбинация ингибитора асне и антагониста 5-нт для лечения когнитивной дисфункции
JP2016508135A5 (https=)
AU2019331665A1 (en) Heterocyclic compounds as AHR modulators
JP2013530130A (ja) ヘテロアリール（アルキル）ジチオカルバメート化合物、その調製方法及び使用
JP2014524449A5 (https=)
JP2014523426A5 (https=)
CN105050602B (zh) 作为pi3激酶抑制剂的吡啶化合物
JP2006518726A5 (https=)
RU2004111787A (ru) Ретиноидные агонисты (1), производные алкилмочевины
JP2012526054A (ja) 複素環置換のジフェニル尿素類誘導体及びその用途
RU2017108909A (ru) Производные изохинолинона, полезные для лечения рака
JP2004518633A5 (https=)
JP2019064976A (ja) 抗がん剤